CLINICAL_TRIALS
trial_result
· 2024-08-13
Clinical Trial Update: Drug Interactions Between Dolutegravir and Escalating Doses of Rifampicin [Phase 4]
Summary
This Phase 4 trial evaluated drug interactions between dolutegravir and escalating doses of rifampicin in people with HIV and tuberculosis. The study has been c…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Helen Reynolds | Conditions: Hiv, Tuberculosis | Phase 4 | Status: COMPLETED